BOLT vs XOM · rev $7.7M vs P/E 24, rev $332.24B
Bolt Biotherapeutics (BOLT) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported XOM revenue for 2025-12-31 was $332.24B. Net income was $28.84B. Revenue was down 5.0% from 2024-12-31 to 2025-12-31. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
BOLT currently screens at market cap $11.3M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the BOLT and XOM stock pages for the full models.
Not investment advice.